Denita Kiya

Associate

Los Angeles + 1.213.243.2605

Connect

Share

Denita Kiya advises public and private companies on mergers and acquisitions and other strategic transactions. She counsels clients in a range of industries, including health care, real estate, life sciences, e-commerce, and fintech.

Representative matters include Verily Health in its spin-out from Alphabet, Inc.

Denita maintains an active pro bono practice, including representing clients seeking habeas relief.

Erfahrung

  • ResMed sells MatrixCare business to Frazier Healthcare PartnersJones Day is advising ResMed Corp. (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, in the $490 million sale of MatrixCare business, an EHR software solution providing support for skilled nursing, senior living and long-term care, life planning communities and home health and hospice care, to Frazier Healthcare Partners, a private equity firm focused exclusively on health care.
  • Verily spins out from Alphabet and raises $300 millionJones Day represented Verily Health in its spin-out from Alphabet, Inc., corporate restructuring and $300 million new money financing.
  • NerdWallet acquires College Finance CompanyJones Day advised NerdWallet, Inc. in the acquisition of College Finance Company, LLC.
  • Labcorp acquires select outreach laboratory assets of Community Health SystemsJones Day advised Labcorp in the $194 million acquisition of select assets and the assumption of certain leases of the ambulatory outreach laboratory services of CHS/Community Health Systems, Inc. health systems in 13 states, including certain patient service centers and in-office phlebotomy locations.
    •

    Bitte beachten Sie vor dem Versenden:

    Die Informationen auf unserer Website sind für den allgemeinen Gebrauch und stellen keine Rechtsberatung dar. Der Versand dieser E-Mail ist nicht dazu bestimmt, ein Mandatsverhältnis zu begründen, und der Erhalt dieser E-Mail stellt kein Mandatsverhältnis dar. Alles, was Sie an jemanden in unserer Kanzlei senden, ist nicht vertraulich oder privilegiert, es sei denn, wir haben zugestimmt, Sie zu vertreten. Wenn Sie diese E-Mail versenden, bestätigen Sie, dass Sie diesen Hinweis gelesen und verstanden haben.